The Valley Desk

NCT00106184 · Interventional trial

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Overall registry status Completed

Phase 2

Conditions Dermatomyositis, Juvenile Dermatomyositis, Myositis, Polymyositis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov